Skip to main content
Premium Trial:

Request an Annual Quote

Emma Green, John Beeler

Inivata has appointed Emma Green head of clinical development and operations and John Beeler vice president of business development. Green will be responsible for clinical development initiatives at the company's laboratories in Cambridge, UK. Beeler will direct business development-related activities, such as partnerships with diagnostic and pharmaceutical companies and academic institutions internationally. 

Green most recently was at Cell Therapy Catapult as head of clinical operations. She previously worked at Pfizer, Aventis, Sosei UK, and Serentis. Beeler was previously the director of theranostics and business development at BioMérieux, where he was responsible for companion diagnostic development and commercialization.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more